Evidence map›Paper›PMID 26779536›Full record

ReviewBioMed research international2015

Relevance of the Carotid Body Chemoreflex in the Progression of Heart Failure.

David C Andrade, Claudia Lucero, Camilo Toledo, Carlos Madrid, Noah J Marcus, Harold D Schultz, Rodrigo Del Rio

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

David C AndradeLaboratory of Cardiorespiratory Control, Center of Biomedical Research, Universidad Autónoma de Chile, 8900000 Santiago, Chile.
Claudia LuceroLaboratory of Cardiorespiratory Control, Center of Biomedical Research, Universidad Autónoma de Chile, 8900000 Santiago, Chile.
Camilo ToledoLaboratory of Cardiorespiratory Control, Center of Biomedical Research, Universidad Autónoma de Chile, 8900000 Santiago, Chile.
Carlos MadridCentro de Fisiología Celular e Integrativa, Clínica Alemana-Universidad del Desarrollo, 7500000 Santiago, Chile.
Noah J MarcusDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA 50312, USA.
Harold D SchultzDepartment of Cellular & Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Rodrigo Del RioLaboratory of Cardiorespiratory Control, Center of Biomedical Research, Universidad Autónoma de Chile, 8900000 Santiago, Chile; Dirección de Investigación, Universidad Científica del Sur, Lima 15067, Peru.
Universidad Autónoma de Chile · CLDes Moines University · USUniversidad del Desarrollo · CLUniversity of Nebraska Medical Center · US

Funding

The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in HeartP01HL062222 · NHLBI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SCHULTZ, HAROLD D · 1999 to 2019
$32.2M
NHLBI NIH HHS P01 HL062222NHLBI NIH HHS P01-HL62222
6 · The paper itself

Abstract

Chronic heart failure (CHF) is a global health problem affecting millions of people. Autonomic dysfunction and disordered breathing patterns are commonly observed in patients with CHF, and both are strongly related to poor prognosis and high mortality risk. Tonic activation of carotid body (CB) chemoreceptors contributes to sympathoexcitation and disordered breathing patterns in experimental models of CHF. Recent studies show that ablation of the CB chemoreceptors improves autonomic function and breathing control in CHF and improves survival. These exciting findings indicate that alterations in CB function are critical to the progression of CHF. Therefore, better understanding of the physiology of the CB chemoreflex in CHF could lead to improvements in current treatments and clinical management of patients with CHF characterized by high chemosensitivity. Accordingly, the main focus of this brief review is to summarize current knowledge of CB chemoreflex function in different experimental models of CHF and to comment on their potential translation to treatment of human CHF.

Indexed as

RespirationCarotid BodyChemoreceptor CellsDisease ProgressionHeart FailureHumansReflexSympathetic Nervous System

Identifiers

PMID26779536
PMCPMC4686619
OpenAlexW2193454110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.